Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
NCT02357992 trial: what clinicians have said so far
Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy
- NCT02357992 ↗
- Completed
- M.D. Anderson Cancer Center
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on NCT02357992 yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT02357992 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 4 posts on X, typically up to 18 once built |
The trial
ClinicalTrials.gov- Official title
- STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy
- Phase
- Phase not applicable
- Status
- Completed
- Conditions
- Lung Cancer
- Interventions
- Stereotactic Body Radiotherapy (SABR)
- Arms
- Stereotactic Radiotherapy (SRT) · Experimental
- Enrollment
- 122
- Primary outcomes
- Number of Participants With Overall Survival (OS) at 3 Years
- Sponsor
- M.D. Anderson Cancer Center with Varian Medical Systems
- Start
- Apr 5, 2010
- Primary completion
- Sep 17, 2021
- Results posted
- Yes
- Registry record
- NCT02357992 · updated Oct 14, 2022
Publications
linked from the registry- Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA; STARS Lung Cancer Trials Group. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol. 2021 Oct;22(10):1448-1457. doi: 10.1016/S1470-2045(21)00401-0. Epub 2021 Sep 13. PubMed 34529930